Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Newport Laboratories is a leading animal health biotechnology company specializing in the development and manufacture of autogenous vaccines for the livestock industry. The company focuses on providing customized biological solutions for swine, cattle, and other production animals when commercial vaccines are unavailable or ineffective against specific farm-site strains. By utilizing advanced diagnostic tools and molecular technology, Newport Laboratories identifies specific pathogens and creates tailored vaccines to address emerging disease threats. Now a part of Boehringer Ingelheim, the company continues to be a critical partner for veterinarians and producers in managing herd health through precision immunology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEWP.